Item 5.07. Submission of matters to a vote of security holders.

ALX Oncology Holdings Inc. (the "Company") held its Annual Meeting of stockholders (the "Annual Meeting") on June 10, 2021. The matters voted upon at the Annual Meeting and the voting results for each proposal are set forth below.

Proposal 1: Election of Three Class I Directors




Name of Director                For     Withheld  Broker Non-Votes

Corey Goodman, Ph.D. 33,898,340 2,307,647 1,259,184 Jason Lettmann

               33,911,262 2,294,725    1,259,184

Sophia Randolph, M.D., Ph.D. 35,309,396 896,591 1,259,184

Each director nominee was duly elected to serve until the 2024 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.

Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm




   For     Against Abstain
37,458,731  4,303   2,137

The stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses